ELC Group establishes global hq in Cambridge, UK
Follows year of exceptional revenue growth for regulatory affairs organisation
ELC Group, a pan-European pharmaceutical regulatory affairs organisation, has opened a new global headquarters in Cambridge, UK.
The move follows a year of exceptional revenue growth for ELC, formerly headquartered in Prague, Czech Republic, and strengthens its ability to serve customers across its major global regions.
Anna Szymanska, general manager of regulatory affairs, will head the Cambridge operation.
Last year ELC doubled revenue in the first quarter and has seen demand soar for its regulatory affairs consulting and commercialisation services across key global markets.
Demand has been particularly strong for pharmacovigilance solutions and regulatory submission services in India and China.
ELC said it would continue to explore acquisition targets and will lead its continued market expansion from the newly opened UK base.
The firm is also exploring commercial opportunities in South Asia.
To support this growth strategy a team of senior regulatory affairs experts and business development personnel will be based in Cambridge, with plans to recruit additional regulatory affairs staff by the end of the year.
Marco Rubinstein, chief executive of ELC Group, said: ‘In tough market conditions we have enjoyed a year of truly outstanding revenue growth. This really demonstrates the value our global customers are deriving from our core offering, and provides an excellent platform for the strategic plans we have in place to expand the breadth and depth of ELC Group’s capabilities.’
